MRSA tester
A product that can perform a rapid test for serious diseases such as meningitis and MRSA is being developed by Atlas Genetics.
A product that can perform a rapid test for serious diseases such as meningitis, chlamydia and the hospital superbug MRSA is being developed by a new company Atlas Genetics, which is being launched using £500,000 funding and the expertise of academics at the
Current hospital tests take up to 72 hours, by which time the patients may have become seriously ill and may have spread the disease. The new product, however, will enable hospitals and eventually GPs to perform tests on the spot and make decisions about treatment within 20 minutes.
In use, the product will analyse a clinical sample of blood, urine or saliva and then indicate the presence, or absence, of DNA from the bacteria causing the disease.
The technology behind it has been developed over the last three years with a team of scientists from the Department of Chemistry at the
Register now to continue reading
Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.
Benefits of registering
-
In-depth insights and coverage of key emerging trends
-
Unrestricted access to special reports throughout the year
-
Daily technology news delivered straight to your inbox
Comment: Engineers must adapt to AI or fall behind
A fascinating piece and nice to see a broad discussion beyond GenAI and the hype bandwagon. AI (all flavours) like many things invented or used by...